News Roundup: Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP), Himax Technologies, Inc. (NASDAQ:HIMX)


Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP)

Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) represented a move of 2.7 percent or $-0.01 per share and closed its previous day trading session at $0.38. 2.14 Million Shares were traded in the last trading session with an Average Volume of 4.45 Million Shares. The stock currently has a Market Capitalization of 94.41 Million.

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. Its lead drug candidate plecanatide is a guanylyl cyclase C receptor agonist, to treat GI disorders, primarily chronic constipation and constipation-predominant- irritable bowel syndrome. It is also engaged in developing receptor agonist for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis. Synergy Pharmaceuticals, Inc. is headquartered in New York, New York.

The stock traded between $0.350 and $2.800 over 1-Year time period showing its price to sales ratio of 2.29. Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.

Right now, the stock has a 50-Day Simple Moving Average of $-58.13 and 200-Day Simple Moving Average of $-75.9. Its Price to Free Cash Flow is 0 and Price to Book of 0.

Analyst’s recommended the stock as 2.7 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) reported its Actual EPS of $-0.14/share. The analysts offering Earnings Estimates for the company were believing that Synergy Pharmaceuticals, Inc. could bring EPS of $-0.14/share. The difference between Actual EPS and Estimated EPS was 0 Percent. Thus showing an Earnings Surprise of 0 Percent.

Himax Technologies, Inc. (NASDAQ:HIMX)

In the last trading session, Himax Technologies, Inc. (NASDAQ:HIMX) added its value by -5.88% closing at the price of $3.68. The stock currently has market capitalization of 624.2 Million, with average volume of 2.35 Million shares.

Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Himax Technologies, Inc. (NASDAQ:HIMX) is showing beta of -0.33. This particular value of beta suggests that Himax Technologies, Inc. (NASDAQ:HIMX) has historically moved -33% for every 100% move in the benchmark, based on price level.

EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Himax Technologies, Inc. (NASDAQ:HIMX) is at $0.14.

The stock currently has RSI of 27.8. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.

Himax Technologies, Inc. designs, develops and markets semiconductors that are critical components of flat panel displays. The Company’s principal products are display drivers for large-sized TFT-LCD panels, which are used in desktop monitors, notebook computers and televisions, and display drivers for small- and medium-sized TFT-LCD panels, which are used in mobile handsets and consumer electronics products such as digital cameras, mobile gaming devices and car navigation displays. In addition, the Company is expanding its product offering to include LCD TV chipset solutions and LCOS microdisplays.

Himax Technologies, Inc. (NASDAQ:HIMX) topped its 52-week high price of $12.10 on 12/08/17 and 52-Week Low Price of $ 3.60 on 12/06/18. The Stock currently has P/E (price to earnings ttm) of 26.67 and Weekly volatility of 6.05% and monthly volatility of 6.66% respectively.